Strong sustenance sales in 360 West, Elysian drive pre-sales: Despite no major launches in Q2FY26, OBEREA reported healthy pre-sales of 1299 crore (down 10% YoY, down 21% QoQ) owing to strong contributions from 360 West ( 446 crore) and Elysian ( 355 crore). Further, its Mulund and Borivali (despite price hikes) projects witnessed healthy sequential improvement post weakness over trailing three quarters. Although on the flip side, Thane project stayed weak over trailing three quarters. Collections too were strong at 1353 crore (up 12% YoY & 36% QoQ)....
About the stock: Mastek Ltd (Mastek) offers data, apps, cloud services to public Geographic strength and strategic focus areas: UK remains Mastek's growth anchor, up 4% QoQ and contributing 65% of revenue, driven by strong demand in Healthcare and Government segments. The company is also restructuring its North America leadership to drive Healthcare growth and emphasis remains on profitability improvement and tighter DSO management.in the Middle East. Continued focus on geo-diversification, AI-led delivery, and mid-market leadership provides visibility for steady, profitable growth through FY2627...
About the stock: IndusInd Bank is a Hinduja group promoted newer age private sector bank and is the fifth largest private bank in India. The bank has full product suite with strong moat in vehicle and micro finance business. The bank has a strong presence with pan India branch network of 3,116...
Component strategy execution to be key factor ahead manufacturing services (EMS) company of India offering comprehensive EMS solutions with specialized focus across product verticals including mobile, television, washing machine, refrigerators, laptop, lighting, telecom, wearables and hearables, AC printed circuit boards (PCBs), etc. Q2FY26 performance: Dixon reported revenue of 14,855 crore (up by (29% YoY/15% QoQ). Mobile and EMS division continued its healthy growth with revenue of 13,361 crore (up by 41% YoY/15% QoQ). Company is in-line to achieve 40-42...
Prudent management, strong execution track record, healthy order book, strong balance sheet and robust return ratios are the key strengths of PSP. Q2FY26 Performance: The standalone revenue of 694 crore, was up 20% YoY, attributable to improved project execution which driven by better workflow, and improved labour activity post monsoon season. EBITDA at 48.1 crore, up 23.8%...
Q2FY26 performance: Consolidated revenue increased by 25.4% YoY (-7.8% QoQ) to Rs 19606.9 crore, led by 21.6% YoY volume growth to 33.85 mtpa and realisation improvement by 3.1% YoY (+s0.3% QoQ). EBITDA/ton improved by 26.1% YoY (-23.7% QoQ) to Rs 914/ton. Subsequently, EBITDA was up 53.3% YoY (-29.8%...
Q2FY26 performance: IDFC First Bank reported a mixed Q2FY26 performance as healthy loan and deposit growth was offset by margin pressure and lower treasury gains. NII rose 6.8% YoY to 5,113 crore, while NIM contracted 12 bps QoQ to 5.6%. Provisions moderated to 1,452 crore, aiding PAT of 352 crore (up 76% YoY, down 24% QoQ). Asset quality improved with GNPA/NNPA at 1.86%/0.52%. Funded assets expanded 19.7% YoY to 2.67 lakh crore led by mortgage, vehicle and...
Strategic capacity expansion and focus on profitability to lead growth: Sales volume was largely inline with expectations at 3% YoY in Q2FY26, as the company remained focused on profitability. Management reiterated that the focus will remain on profitable growth going forward and quality of sales through product mix and balancing strategy across micro-markets based on utilization and demand-supply dynamics. On the capacity addition front, the ongoing expansion at Belgaum (3 mtpa) and Pune (3 mtpa) are on track and expected by FY27E end. Further, the planned 6 mtpa expansion at Kadapa (AP)...
Recently acquired speciality chemical company i.e. Aquapharm Chemicals Q2FY26 Result: On the consolidated basis, at PCBL, net sales for Q2'26 came in at 2,164 crore with carbon black sales volumes at 162 kt (up 9% YoY & 5% QoQ) and realisation at 99/kg (vs. 108/kg in Q1FY26). EBITDA for the quarter came in at 266 crore with margins at 12.3% (down 280 bps QoQ). PAT for Q2FY26 stood at 62 crore, down 50% YoY. EBITDA/tonne in carbon black space for Q2'26 stood at ~ 14,250/tonne vs. ~17,800 clocked Q1FY26. Global uncertainty to weigh on near term performance: For Q2'26;...
Healthy revival in Q2; further recovery expected in H2FY26 Q2FY26 performance: Federal Bank delivered a healthy revival in Q2FY26, on the back of margin recovery, healthy fees income, and steady credit cost. NIM expanded 12 bps sequentially to 3.06% aided by lower funding costs and a better loan mix towards mid-yield segments. Advances rose 6% YoY (2% QoQ) to 2,55,613 crore, with traction in commercial banking while deposits rose 11% YoY (2.5% QoQ) to 2,88,920 crore, with CASA ratio improving 66 bps QoQ to 31.01%. Fees income surged 13% QoQ to 886 crore. Credit cost moderated to ~50 bps, in...
